News
Cronos Australia (ASX: CAU) has changed its name to Vitura Health - VIT (ASX: VIT).
Below are the previous articles from Cronos Australia (ASX: CAU):
RELATED STOCKHEAD STORIES
Health & Biotech
Cannabis play Cronos delivers record quarter with $18m in cash receipts, sets up for long-term market leadership
Health & Biotech
Cronos Australia just announced a 1100pc increase in revenue to ~$27.37 million in H1 FY22 and delivered a ~$3.37m net profit
News
These are 8 ASX stocks currently trading at 12-month highs (and lows)
News
ASX Small Cap Lunch Wrap: Who’s been left behind today?
Health & Biotech
What’s the best pot stock of 2021? And who’s targeting market domination in 2022?
News
Closing Bell: ASX falls despite flurry of merger and acquisition action
Escrow Watch
Escrow Watch: Which company that’s shrunk 66pc since its IPO has put off a shares release?
Health & Biotech
ASX Health Stocks: Cronos jumps 7pc after booking $1.1m of medicinal cannabis revenues in Q1
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
ASX Small Cap Lunch Wrap: Who wore it best today?
Health & Biotech
ASX Health Stocks: Cannabis play Cronos scoots 19% higher on merger news, Telix gets FDA nod for clinical trial
News
10 at 10: These ASX stocks are the central point of investors’ attention this morning
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Weed Week: Europe or North America, where’s the place to be for ASX cannabis stocks?
News